Most-Read Print Managed Healthcare Executive® Articles of 2021
Many of the most-read articles from the print issues of Managed Healthcare Executive® focused on the cost of therapies.
The Price Tags on the COVID-19 Vaccines
Governments are the only buyers so far, and the amounts they are paying varies.
The Pandemic Pause: When Cancer Care Was Put on Hold
Screening and some care have been canceled or deferred. Will more illness and deaths result?
Generic Drug Price Tags: Too High. And Too Low. Competition Can Help Create an In-Between.
Low prices and some gaming of regulations can drive out competitors and create monopolies that allow generic makers to jack up their prices. Experience has shown that it often takes multiple generics to achieve the promised-for downward pressure on prices.
The Rise in Formulary Exclusions
PBMs say exclusions are important for negotiating lower prices on behalf of health plans and members. Some payer and provider groups say they interfere with patient access to medicines.
How ‘White Bagging’ Affects Patients, Physicians and 340B Funding
Having specialty pharmacies fill prescriptions may lower costs, but critics of the practice see safety issues and other drawbacks.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
